Why Pet Health Is The Focus Of A New Biotech Sector

Why Pet Health Is The Focus Of A New Biotech Sector

By Cathy Yarbrough, Contributing Editor   For Aratana Therapeutics, 2016 was a banner year. The biotech company, founded in 2010, achieved FDA approvals for three of its 10 pipeline drugs. Last year the Kansas City-based company also forged a global partnership with...